Fred Weaver is a Cardiology physician affiliated with University of Southern California. OpenAlex indexes 441 publications with 10,189 citations (h-index 53); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Vascular Surgery profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Baroreflex Activation Therapy for Heart Failure
Sponsor: CVRx, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 1997–2002 per NIH RePORTER. The latest:
- FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
University of Southern California
FY2002M01RR000043 - FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
University of Southern California
FY2001$155,764M01RR000043 - FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
University of Southern California
FY2001M01RR000043
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology
2020 - Cardiac and Vascular Surgery–Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group
Journal of the American Heart Association
2018 - Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials
Journal of the American College of Cardiology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Andrew Moshfeghi, MD
University of Southern California
Kenneth Nies, MD
University of Southern California
Joseph Cadden, MD
University of Southern California
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”